Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Emergent BioSolutions Inc. | a322-lindhalcertificat.htm |
| EX-32.1 - EXHIBIT 32.1 - Emergent BioSolutions Inc. | a312-lindhalcertificat.htm |
| EX-31.1 - EXHIBIT 31.1 - Emergent BioSolutions Inc. | a311-kramercertificati.htm |
| EX-10.5 - EXHIBIT 10.5 - Emergent BioSolutions Inc. | a105-mod1acam2000.htm |
| EX-10.4 - EXHIBIT 10.4 - Emergent BioSolutions Inc. | a104-bardaadmorder.htm |
| EX-10.3 - EXHIBIT 10.3 - Emergent BioSolutions Inc. | a103-mod20bardaadm.htm |
| EX-10.2 - EXHIBIT 10.2 - Emergent BioSolutions Inc. | a102-mod19bardaadm.htm |
| EX-10.1 - EXHIBIT 10.1 - Emergent BioSolutions Inc. | a101-bardaadm2012agree.htm |
| 10-Q - 10-Q - Emergent BioSolutions Inc. | ebs-2020x06x3010xq.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Emergent BioSolutions Inc. (the "Company") for the period ended June 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Robert G. Kramer, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: July 31, 2020
/s/ROBERT G. KRAMER
Robert G. Kramer
Chief Executive Officer